Literature DB >> 32067674

High-risk neuroblastoma: where do we go?

A Cañete1.   

Abstract

Entities:  

Year:  2020        PMID： 32067674     DOI： 10.1016/j.annonc.2019.12.003

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma.

Authors:  Tomoko Tanaka; Yuichi Togashi; Yuki Takeuchi; Mayumi Higashi; Shigehisa Fumino; Tatsuro Tajiri
Journal:  Pediatr Surg Int       Date:  2021-01-04       Impact factor: 1.827

2.  Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.

Authors:  Bo Chen; Zhongyan Hua; Xiuni Qin; Zhijie Li
Journal:  Neurochem Res       Date:  2020-10-26       Impact factor: 3.996

3.  Anti-tumor effect of Huaier extract against neuroblastoma cells in vitro.

Authors:  Dong-Qing Xu; Xiao-Jun Yuan; Hidemi Toyoda; Masahiro Hirayama
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

4.  Suppression of endoplasmic reticulum stress-dependent autophagy enhances cynaropicrin-induced apoptosis via attenuation of the P62/Keap1/Nrf2 pathways in neuroblastoma.

Authors:  Randong Yang; Shurong Ma; Ran Zhuo; Lingqi Xu; Siqi Jia; Pengcheng Yang; Ye Yao; Haibo Cao; Liya Ma; Jian Pan; Jian Wang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.